Old Web
English
Sign In
Acemap
>
authorDetail
>
Xiaoge Kou
Xiaoge Kou
Xinxiang Medical University
Medicine
Internal medicine
Clinical trial
Nausea
Pathology
4
Papers
23
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Efficacy of HX008 in high microsatellite instability/mismatch repair–defificient (MSI-H/dMMR) solid tumors: Results from a multicenter phase II open-label study.
2021
Journal of Clinical Oncology
Jing Huang
Yan Song
Suxia Luo
Xianli Yin
Enxiao Li
Hui Wang
Yifu He
Zhihui Liu
Qingxia Fan
Xinjun Liang
Yongqian Shu
Yunpeng Liu
Nong Xu
Shu Zhang
Zhixiang Zhuang
Jingdong Zhang
Xiaoge Kou
Fen Wang
Xiao-Dong Zhu
Shengmian Li
Show All
Source
Cite
Save
Citations (0)
HX008, an anti-PD1 antibody, plus irinotecan as second-line treatment for advanced gastric or gastroesophageal junction cancer: a multicenter, single-arm phase II trial.
2020
Journal for ImmunoTherapy of Cancer
Yan Song
Ning Li
Qun Li
Xinjun Liang
Shu Zhang
Qingxia Fan
Xianli Yin
Zhixiang Zhuang
Yunpeng Liu
Jingdong Zhang
Xiaoge Kou
Haijun Zhong
Xiaofei Wang
Yiwei Dou
Jing Huang
Show All
Source
Cite
Save
Citations (1)
HX008, an anti-PD1 antibody, plus irinotecan as second-line treatment for advanced gastric adenocarcinoma: A phase II clinical trial.
2020
Journal of Clinical Oncology
Yan Song
Ning Li
Lan Mu
Shu Zhang
Qingxia Fan
Xinjun Liang
Xianli Yin
Zhixiang Zhuang
Yunpeng Liu
Jingdong Zhang
Xiaoge Kou
Haijun Zhong
Jing Huang
Show All
Source
Cite
Save
Citations (0)
Kanglaite injection combined with chemotherapy versus chemotherapy alone in the treatment of advanced non-small cell lung carcinoma.
2014
Journal of Cancer Research and Therapeutics
Xiaohong Liu
Qinghui Yang
Yuling Xi
Kewei Yu
Weizhen Wang
Xiangmei Zhao
Xiaoge Kou
Show All
Source
Cite
Save
Citations (22)
1